Elevance Health Inc.
11/10/2025 | Press release | Distributed by Public on 11/10/2025 16:03
Regulation FD Disclosure (Form 8-K)
Item 7.01 - Regulation FD Disclosure
Officers of Elevance Health, Inc. (the "Company") expect to speak with investors over the next week. During these meetings, Company officers expect to reaffirm the Company's shareholders' earnings guidance for full year 2025 to be approximately $24.70 per diluted share, including approximately $5.30 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders' earnings to be approximately $30.00 per diluted share. This does not include any other adjustment items beyond those reported in the Company's third quarter 2025 earnings.
During these meetings, Company officers are also expected to reaffirm full year 2025 benefit expense ratio guidance of approximately 90.0%.
The Company notes that these expectations reflect management's current view of market conditions, operational performance, the regulatory and policy landscape, and refinement of key business assumptions, including cost trends and medical claims payable estimates. To the extent business factors or assumptions change, the Company's actual results could materially differ from management's current guidance.
None of the information furnished in Item 7.01 hereto shall be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.
Elevance Health Inc. published this content on November 10, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on November 10, 2025 at 22:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]